Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer. Swiecicki PL, Yilmaz E, Rosenberg AJ, Fujisawa T, et al. J Clin Oncol 2024 Oct 31:JCO2400646. doi: 10.1200/JCO.24.00646.

Read + Share

Amedeo Smart

Independent Medical Education

Swiecicki PL, Yilmaz E, Rosenberg AJ, Fujisawa T, et al. Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer. J Clin Oncol 2024 Oct 31:JCO2400646. doi: 10.1200/JCO.24.00646.
PMID: 39481054